MSA
WST icon

MUFG Securities Americas’s West Pharmaceutical WST Stock Holding History

MUFG Securities Americas’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$764K Buy
2,128
+137
+7% +$41.9K 0.04% 344
2026
Q1 		$499K Buy
1,991
+53
+3% +$13.2K 0.03% 395
2025
Q4 		$533K Sell
1,938
-1
-0.1% -$274 0.03% 384
2025
Q3 		$509K Buy
1,939
+347
+22% +$84.3K 0.03% 384
2025
Q2 		$348K Buy
1,592
+310
+24% +$66.3K 0.03% 407
2025
Q1 		$287K Buy
1,282
+213
+20% +$58.7K 0.03% 400
2024
Q4 		$350K Buy
+1,069
New +$336K 0.04% 338

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

MUFG Securities Americas's WST Position: Q2 2026 in Review

MUFG Securities Americas increased its West Pharmaceutical (WST) stake by 6.9% in Q2 2026, buying an estimated $41.9K and bringing the position to 2,128 shares worth $764K. The position accounts for 0.04% of the portfolio, ranked #344.

MUFG Securities Americas first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • MUFG Securities Americas held 2,128 shares of West Pharmaceutical worth $764K as of Q2 2026.
  • MUFG Securities Americas bought 137 West Pharmaceutical shares in Q2 2026, an estimated $41.9K.
  • West Pharmaceutical made up 0.04% of MUFG Securities Americas's portfolio in Q2 2026, its #344 holding.
  • MUFG Securities Americas first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.